The relationship of glycine-rich -glycoprotein to factor B in the properdin system and to the cobra factor-binding protein of huan serum
- PMID: 4734403
- PMCID: PMC2139488
- DOI: 10.1084/jem.137.2.424
The relationship of glycine-rich -glycoprotein to factor B in the properdin system and to the cobra factor-binding protein of huan serum
Abstract
Factor B activity of the properdin system was found to be identical with purified glycine-rich beta-glycoprotein (GBG) but was distinct from the normal human serum protein capable of forming a C3-inactivating complex with a protein from cobra venom (CoF). Factor B activity coincided with electrophoretically separated GBG genetic variants, whereas the CoF-binding protein did not. GBGase destroyed factor B as it cleaved GBG but did not destroy the C3-inactivating activity of the CoF-binding protein. During incubation of serum with CoF, GBG did not change in molecular size, nor was there any coincidence in the immunoelectrophoretic mobilities of CoF and GBG. It was not possible to precipitate labeled CoF incubated with serum by anti-GBG, nor labeled GBG from serum incubated with CoF by anti-CoF. The CoF-binding capacity of serum was 2 mg/100 ml or less or under 6.5% of the serum concentration of GBG. When labeled CoF was added to serum below the binding capacity, complete complexation of the CoF was demonstrated, whereas CoF was largely uncomplexed when CoF was added in amounts equimolar to GBG.
Similar articles
-
Studies on the properdin system: isolation of a heat-labile factor from guinea pig serum related to a human glycine rich beta-glycoprotein (GBG or factor B).J Immunol. 1972 Dec;109(6):1174-81. J Immunol. 1972. PMID: 4628703 No abstract available.
-
Formation and composition of the C3 activating enzyme complex of the properdin system. Sequential assembly of its components on solid-phase trypsin-agarose.Z Immunitatsforsch Exp Klin Immunol. 1975 Jul;149(5):440-55. Z Immunitatsforsch Exp Klin Immunol. 1975. PMID: 126576
-
Formation and function of a complex of the C3 proactivator with a protein from cobra venom.J Exp Med. 1973 Feb 1;137(2):451-60. doi: 10.1084/jem.137.2.451. J Exp Med. 1973. PMID: 4734404 Free PMC article.
-
Inactivator of the third component of complement as an inhibitor in the properdin pathway.Proc Natl Acad Sci U S A. 1972 Oct;69(10):2910-3. doi: 10.1073/pnas.69.10.2910. Proc Natl Acad Sci U S A. 1972. PMID: 4507613 Free PMC article.
-
The complement system of man. I.N Engl J Med. 1972 Sep 7;287(10):489-95. doi: 10.1056/NEJM197209072871005. N Engl J Med. 1972. PMID: 4114930 Review. No abstract available.
Cited by
-
Complete absence of the third component of complement in man.J Clin Invest. 1975 Sep;56(3):703-10. doi: 10.1172/JCI108141. J Clin Invest. 1975. PMID: 1159084 Free PMC article.
-
The use of antibody-coated liposomes as a target cell model for antibody-dependent cell-mediated cytotoxicity.Clin Exp Immunol. 1979 Jan;35(1):149-54. Clin Exp Immunol. 1979. PMID: 428143 Free PMC article.
-
Properdin factor D. II. Activation to D by properdin.J Exp Med. 1974 Aug 1;140(2):426-36. doi: 10.1084/jem.140.2.426. J Exp Med. 1974. PMID: 4211020 Free PMC article.
-
Metabolic studies of the third component of complement and the glycine-rich beta glycoprotein in patients with hypocomplementemia.J Clin Invest. 1974 Jun;53(6):1578-87. doi: 10.1172/JCI107708. J Clin Invest. 1974. PMID: 4830223 Free PMC article.
-
Properdin factor D: characterization of its active site and isolation of the precursor form.J Exp Med. 1974 Feb 1;139(2):355-66. doi: 10.1084/jem.139.2.355. J Exp Med. 1974. PMID: 4855753 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous